SRp55 activators refer to a specific class of chemical compounds that interact with and modulate the activity of the SRp55 protein. SRp55, also known as Serine/arginine-rich splicing factor 6 (SRSF6), is a crucial component of the spliceosome, a complex molecular machine responsible for pre-mRNA splicing in eukaryotic cells. Pre-mRNA splicing is a fundamental process in gene expression, where introns are removed, and exons are joined together to create mature mRNA molecules. The correct splicing of pre-mRNA is essential for generating functional and diverse protein products from a single gene. SRp55 activators are characterized by their ability to influence the splicing activity of SRp55. These compounds may work by binding to SRp55 and modifying its function, affecting its interactions with pre-mRNA and other splicing factors. The precise mechanisms by which SRp55 activators influence splicing are an active area of research, and they may have implications for the regulation of alternative splicing, a process that generates multiple mRNA isoforms from a single gene. Alternative splicing plays a crucial role in expanding the proteome's diversity and can have profound effects on cellular function and phenotype.
Researchers study SRp55 activators to gain insights into the intricate process of pre-mRNA splicing and its regulation. Understanding the molecular mechanisms behind splicing factor activation can shed light on how cells control gene expression and generate functional diversity in proteins. Additionally, these compounds can serve as valuable tools for manipulating splicing events in the laboratory, enabling scientists to investigate the functional consequences of altered splicing patterns in various cellular and developmental contexts. The study of SRp55 activators contributes to our broader understanding of gene regulation and the intricate machinery that governs the expression of genetic information.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
This short-chain fatty acid, often used in epigenetic studies, can influence alternative splicing by modifying chromatin structure, potentially affecting SRp55. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor, 5-Azacytidine, can alter gene expression and potentially splicing factor activity, including SRp55. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
As a histone deacetylase inhibitor, Trichostatin A can modify chromatin architecture, indirectly impacting splicing factor functions. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid, involved in gene transcription regulation, may have downstream effects on splicing factors, including SRp55. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
Cholecalciferol, through its receptor-mediated gene regulation, might influence splicing factors indirectly. | ||||||
Spliceostatin A | 391611-36-2 | sc-507481 | 1 mg | $1800.00 | ||
While primarily an inhibitor, Spliceostatin A's influence on general splicing machinery could indirectly affect SRp55's activity. | ||||||
Pladienolide B | 445493-23-2 | sc-391691 sc-391691B sc-391691A sc-391691C sc-391691D sc-391691E | 0.5 mg 10 mg 20 mg 50 mg 100 mg 5 mg | $299.00 $5699.00 $11099.00 $25500.00 $66300.00 $2875.00 | 63 | |
This compound, known for affecting splicing, may have an indirect effect on SRp55 through broad splicing factor modulation. | ||||||
Ispinesib | 336113-53-2 | sc-364747 | 10 mg | $505.00 | ||
While primarily a kinesin inhibitor, Ispinesib can affect cellular processes that indirectly modify splicing factor activity, including SRp55. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1, a BET bromodomain inhibitor, may influence transcription and, consequently, splicing factor activity, potentially impacting SRp55. | ||||||